Brexpiprazole

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 544 publications

Drugs for dementia.

Drugs for dementia.

Journal: The Medical letter on drugs and therapeutics

Published: March 24, 2026

Antipsychotics in Children and Adolescents with Schizophrenia-Spectrum Disorders: A Systematic Review, Meta-Analysis, and Long-Term Prospective Evidence.

Antipsychotics in Children and Adolescents with Schizophrenia-Spectrum Disorders: A Systematic Review, Meta-Analysis, and Long-Term Prospective Evidence.

Journal: Journal of child and adolescent psychopharmacology

Published: March 10, 2026

Brexpiprazole for treating agitation in different groups of people with Alzheimer's dementia: a plain language summary.

Brexpiprazole for treating agitation in different groups of people with Alzheimer's dementia: a plain language summary.

Journal: Neurodegenerative disease management

Published: February 14, 2026

Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence.

Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence.

Journal: Epidemiology and psychiatric sciences

Published: February 11, 2026

Evaluation of the Safety of Taking Brexpiprazole During the Lactation Period.

Evaluation of the Safety of Taking Brexpiprazole During the Lactation Period.

Journal: Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine

Published: February 06, 2026

Lumateperone (Caplyta) for adjunctive treatment of depression.

Lumateperone (Caplyta) for adjunctive treatment of depression.

Journal: The Medical letter on drugs and therapeutics

Published: January 23, 2026

Design, Optimization, and In Vitro Evaluation of Lactoferrin-Coated Brexpiprazole-Loaded Nanostructured Lipid Carriers for Brain Targeting.

Design, Optimization, and In Vitro Evaluation of Lactoferrin-Coated Brexpiprazole-Loaded Nanostructured Lipid Carriers for Brain Targeting.

Journal: AAPS PharmSciTech

Published: January 19, 2026

Brexpiprazole side-effect profile in people with agitation in Alzheimer's dementia: a plain language summary.

Brexpiprazole side-effect profile in people with agitation in Alzheimer's dementia: a plain language summary.

Journal: Current medical research and opinion

Published: January 14, 2026

Pharmacological management of agitation in dementia: An evidence-based review with expert consensus.

Pharmacological management of agitation in dementia: An evidence-based review with expert consensus.

Journal: Journal of the Chinese Medical Association : JCMA

Published: January 13, 2026

Brexpiprazole induces acute cardiotoxicity via disrupting calcineurin/NFAT and calcium signaling pathway: A validation from biochemical, echocardiographic, histological, and computational analysis.

Brexpiprazole induces acute cardiotoxicity via disrupting calcineurin/NFAT and calcium signaling pathway: A validation from biochemical, echocardiographic, histological, and computational analysis.

Journal: Tissue & cell

Published: January 08, 2026

Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of Phase 3 clinical trials in adults and adolescents.

Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of Phase 3 clinical trials in adults and adolescents.

Journal: Psychiatry research

Published: January 02, 2026

Efficacy and safety of 2-4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta-analysis.

Efficacy and safety of 2-4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta-analysis.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: December 29, 2025

Showing 1-12 of 544

Last Updated: 04/28/2026